Karnataka govt to set up ICUs at COVID Care Centres

Mangaluru/Mysuru, May 19: Though the Karnataka government permitted the private buses, operators in Dakshina Kannada district have decided not to operate buses until May end. In Mysuru district too the private buses remained off the roads.

Dakshina Kannada Bus Owners’ Association President Dilraj Alva said “Technically, private bus operators are not able to operate services as all of us have surrendered our permits. If we start services we will have to pay the tax for entire month. Hence, we have decided to resume bus services from June 1.”

The private buses had suspended their services since March 24.

In addition, bus owners also have two more demands which the state government needs to consider on priority, he said.

“We have requested the government to exempt private buses from paying tax for the next six months. We were not plying buses during lockdown and it will be tough for us in the next three months to operate as per new conditions.”

“The government has allowed only 30 persons in each bus to maintain social distancing. In addition, we have been urging the state government for bus fare revision since 2013. The government has revised the bus fares of KSRTC twice after that,” Alva said adding that bus owners will be meeting Mangaluru RTO on Tuesday.

Kalaburagi, Mar 25: Three coronavirus suspect persons who did not stay home during their mandatory 14-day quarantine period had first information report (FIRs) booked against them in police stations in Kalaburagi town in Karnataka.   

The district administration took this action after it came to know that the three pesons were mingling in the public despite being told to stay home to avoid passing on the coronavirus.

Cases have been booked against them under IPC sections 188 and 271, deputy commissioner B Sharath said.

Stringent action would be taken against them, he said, for not only threatening the health of their family members but society at large.

“The administration will stop at nothing to safeguard public health in this time of emergency,” Sharath said.

People moving around on motorbikes without a proper reason will have their bikes seized. Prohibitory order under Section 144 of CrPC will remain in force until further orders, he said.  

Mar 5: The government on Thursday asserted that there is no shortage of raw ingredients or medicines in the country as it has taken various initiatives to tackle the challenge posed by the coronavirus outbreak.

All initiatives are also being taken to ensure that there is no impact of the disease in India, Minister of Chemicals and Fertilizers D V Sadananda Gowda said.

"There is no shortage of any APIs in the country. We have sufficient APIs (active pharmaceutical ingredients) and medicines in the country," he said.

Gowda was addressing the 5th international exhibition and conference on the pharmaceutical and medical industry organised by the Department of Pharmaceuticals, Gujarat government and industry chamber Ficci here.

For another three months there is no shortage for undertaking production in the pharma sector, he added.

"Our government has taken all initiatives to ensure that as far as our country is concerned the coronavirus should be stopped, and there is no hazard as far as this issue is concerned," Gowda reiterated.

Coronavirus is a challenge and "we should make all efforts that need to be taken..., " he added.

On Tuesday, India, the world's largest maker of generic drugs, restricted the export of common medicines such as paracetamol and 25 other pharmaceutical ingredients and drugs made from them, as it looks to prevent shortages amid concerns of the coronavirus outbreak turning into a pandemic.

Besides over-the-counter painkiller and fever reducer paracetamol, drugs restricted for exports included common antibiotics metronidazole, and those used to treat bacterial and other infections as well as Vitamin B1 and B12 ingredients.

A notification by the Directorate General of Foreign Trade (DGFT) had said the export of 26 active pharmaceutical ingredients (APIs) and formulations would require licence.